Susanne Herz | Researchain

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Susanne Herz is active.

Explore More

Publication

Featured researches published by Susanne Herz.

Oncologist | 2015

Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.

Christian M. Kurbacher; Olympia Horn; Jutta A. Kurbacher; Susanne Herz; Ann Tabea Kurbacher; Ralf Hildenbrand; Reinhardt Bollmann

Journal of Clinical Oncology | 2016

Anti-HER2 treatment in advanced metastatic HER2-negative breast cancer patients with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells.

Christian M. Kurbacher; Christian Eichler; Annegret Quade; Gerhard Kunstmann; Susanne Herz; Jutta A. Kurbacher; Mathias Warm

Journal of Clinical Oncology | 2018

Treating recurrent tuboovarian carcinoma with multiple lines of bevacizumab-based therapy: Feasibility and effectiveness in the clinical routine.

Christian M. Kurbacher; Valérie Kallage; A. Tabea Kurbacher; Susanne Herz; Alexander Schott; Gabriele Kolberg; Claudia Schweitzer; Jutta A. Kurbacher

Journal of Clinical Oncology | 2018

Sensor-controlled scalp cooling for chemotherapy-induced alopecia: Safety and effectiveness in primary breast cancer patients exposed to anthracyclines and/or taxanes in the neoadjuvant or adjuvant setting.

Christian M. Kurbacher; Susanne Herz; A. Tabea Kurbacher; Gabriele Kolberg; Nele Kettelhoit; Jutta A. Kurbacher

Journal of Clinical Oncology | 2017

Direct effects on bone metabolism induced by perioperative anthracycline- and/or taxane-based chemotherapy depend on the menopausal status of patients with primary breast cancer.

Nadine Rauschenbach; A. Tabea Kurbacher; Susanne Herz; Jutta A. Kurbacher; Katja Monreal; Sandra Sperling; Christian M. Kurbacher

Journal of Clinical Oncology | 2017

Bevacizumab-based therapy in patients with heavily pretreated ovarian and other Mullerian tract cancers.

Jutta A. Kurbacher; Jutta Lepique; Susanne Herz; Gabriele Wessling; Christian M. Kurbacher

Journal of Clinical Oncology | 2017

Effectiveness of targeting HER2 in heavily pretreated patients with occult HER2-positive (tissue-negative, serum-positive and/or HER2-positive circulating tumor cells) metastatic breast cancer in the clinical routine.

Christian M. Kurbacher; Annegret Quade; Gerhard Kunstmann; Susanne Herz; Jutta A. Kurbacher; Mathias A. Warm

Journal of Clinical Oncology | 2016

Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in women treated for either breast or female genital tract cancer: A German experience using the Paxman system.

Christian M. Kurbacher; Susanne Herz; Gabriele Kolberg; Nele Kettelhoit; Claudia Schweitzer; Katja Monreal; Jutta A. Kurbacher

Journal of Clinical Oncology | 2016

Incidence of abnormal HER2 values in the serum of breast cancer patients: influence of disease stage and HER2 status.

Annegret Quade; Susanne Herz; Jutta A. Kurbacher; Gustav Quade; Carsten Bartling; Gabriele Wessling; Katja Monreal; Christian M. Kurbacher

The Breast | 2015

PO141 SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS

Christian M. Kurbacher; Annegret Quade; Gerhard Kunstmann; Susanne Herz; Jutta A. Kurbacher; Matthias R. Warm

Explore More

Collaboration

Dive into the Susanne Herz's collaboration.

Top Co-Authors

Jutta A. Kurbacher

University of Erlangen-Nuremberg

View shared research outputs

Top Co-Authors

Christian M. Kurbacher

University of Erlangen-Nuremberg

View shared research outputs

Top Co-Authors

Gustav Quade

University of Bonn

View shared research outputs

Top Co-Authors

Mathias Warm

University of Cologne

View shared research outputs

Explore More

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot

Dive into the research topics where Susanne Herz is active.

Publication

Featured researches published by Susanne Herz.

Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.

Anti-HER2 treatment in advanced metastatic HER2-negative breast cancer patients with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells.

Treating recurrent tuboovarian carcinoma with multiple lines of bevacizumab-based therapy: Feasibility and effectiveness in the clinical routine.

Sensor-controlled scalp cooling for chemotherapy-induced alopecia: Safety and effectiveness in primary breast cancer patients exposed to anthracyclines and/or taxanes in the neoadjuvant or adjuvant setting.

Direct effects on bone metabolism induced by perioperative anthracycline- and/or taxane-based chemotherapy depend on the menopausal status of patients with primary breast cancer.

Bevacizumab-based therapy in patients with heavily pretreated ovarian and other Mullerian tract cancers.

Effectiveness of targeting HER2 in heavily pretreated patients with occult HER2-positive (tissue-negative, serum-positive and/or HER2-positive circulating tumor cells) metastatic breast cancer in the clinical routine.

Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in women treated for either breast or female genital tract cancer: A German experience using the Paxman system.

Incidence of abnormal HER2 values in the serum of breast cancer patients: influence of disease stage and HER2 status.

PO141 SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS

Collaboration

Dive into the Susanne Herz's collaboration.